Background: Adverse events (AEs) related to cancer treatment represent a valuable source of information that can be used to adjust therapy for individual patients. The NIH developed the Common Terminology Criteria for Adverse Events…
Continue Reading
The Stark Reality of Outdated Kidney Care
Imagine receiving a diagnosis of a life-threatening illness—only to discover that your physician is restricted to treatments and medical tools from the early 2000s, despite the existence of…
Memorial Sloan Kettering Cancer Center and UnitedHealthcare are locked in a high-stakes contract negotiation that could significantly impact cancer patients across the region. The renowned cancer treatment facility has issued warnings to patients about…
Continue Reading
Tim Barrow-Williams, Head of Drug Delivery at PA Consulting
Bill Hartman, Pharma and Medtech Design Expert at PA Consulting
Last year, the American Cancer Society predicted that in 2024, the US would reach two million annual…
Continue Reading
The Growing Complexity of Modern Oncology
Cancer care has evolved dramatically in recent years. What oncologists once treated as unified diseases are now recognized as numerous subtypes, each demanding tailored treatment approaches based on rapidly…
Background: Background: Rehabilitation is considered a fundamental component of cancer treatment, especially for patients undergoing cancer surgery. In contrast to conventional rehabilitation education, digital rehabilitation has the potential to improve patients’ access to post-operative…
Continue Reading
BREAKTHROUGH EXPANSION FOR PROSTATE CANCER THERAPY
Novartis has announced a significant development in prostate cancer treatment with the FDA‘s expanded approval of Pluvicto (lutetium Lu 177 vipivotide tetraxetan). This radioligand therapy is now available for…
Breakthrough Cancer Treatment Receives IDE Approval
Alpha Tau Medical Ltd. has achieved a significant milestone in cancer treatment innovation. The FDA has granted an Investigational Device Exemption (IDE) for a pilot study using their revolutionary…
What You Should Know:
– Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has announced a collaboration with the National Cancer Institute (NCI), part of the U.S. National Institutes of Health (NIH).
–…
Continue Reading
Dr. Sandeep Jain explores available treatment for his patients providing them options that achieve the best possible outcome and quality of life. When a 55-year-old patient arrived at Minnesota Oncology with a rare and aggressive…
Continue Reading
